Sumitomo Mitsui Trust Group
DRNA

Sumitomo Mitsui Trust Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,901
Closed -$482K – 1231
2021
Q3 		$482K Sell
23,901
-432,596
-95% -$11.9M ﹤0.01% 1102
2021
Q2 		$17M Buy
+456,497
New +$14M 0.01% 744

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group's DRNA Position: Q4 2021 in Review

Sumitomo Mitsui Trust Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 23,901 shares — an estimated $482K sold.

Sumitomo Mitsui Trust Group first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $17M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • Sumitomo Mitsui Trust Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 23,901 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $482K.
  • Sumitomo Mitsui Trust Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
  • Sumitomo Mitsui Trust Group's Dicerna Pharmaceuticals, Inc. position peaked at $17M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2021, filed 2 Feb 2022.